The Genzyme (GENZ) play is about more than Sanofi-Aventis (SNY) looking for growth. It reflects...

|About: Sanofi (SNY)|By:, SA News Editor

The Genzyme (GENZ) play is about more than Sanofi-Aventis (SNY) looking for growth. It reflects Big Pharma's push into treating rare illnesses, with the assumption that niche diseases can be a good way to fatten margins, and product pipelines, that are under pressure elsewhere.